Keith Orford

SR. VP, CLINICAL DEVELOPMENT, Calithera Biosciences, Inc.

Companies

Calithera Biosciences, Inc.Board member Nov 9, 2021 to Jun 3, 2022¹
Calithera Biosciences, Inc.SR. VP, CLINICAL DEVELOPMENT May 3, 2016 to Nov 12, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Calithera Biosciences, Inc.66,094 shares³Nov 11, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 11, 2021Sold 48,190 shares at $0.88 of Calithera Biosciences, Inc.³
Nov 10, 2021Sold 30,000 shares at $0.86 of Calithera Biosciences, Inc.³
Nov 9, 2021Sold 51,810 shares at $0.84 of Calithera Biosciences, Inc.⁴
Nov 5, 2021Granted 30,000 shares of Calithera Biosciences, Inc.⁴
Oct 27, 2021Granted 90,000 shares of Calithera Biosciences, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCalithera Biosciences, Inc., Board member
2
SEC EDGARCalithera Biosciences, Inc., SR. VP, CLINICAL DEVELOPMENT
3
SEC EDGARCalithera Biosciences, Inc. shares after the filing of Nov 11, 2021
4
SEC EDGARForm 4 filed Nov 9, 2021
5
SEC EDGARForm 4 filed Oct 29, 2021